German CRO harmonizes patient health data from multiple sources to boost clinical study efficiency

德国CRO协调来自多个来源的患者健康数据，以提高临床研究效率

BARCELONA, Spain, Sept. 21, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that palleos healthcare has selected Veeva Vault Clinical Data Management Suite (CDMS) with Veeva Vault EDC and Veeva CDB (clinical database) to connect all clinical study data on one platform. A unified view of clinical data from wearables and other sources offers palleos healthcare greater visibility and control to adapt studies in real time..

西班牙巴塞罗那，2023年9月21日/PRNewswire/-Veeva Systems（纽约州：VEEV）今天宣布palleos healthcare选择Veeva穹窿临床数据管理套件（CDMS）与Veeva穹窿EDC和Veeva CDB（临床数据库）连接一个平台上的所有临床研究数据。来自可穿戴设备和其他来源的临床数据的统一视图为palleos healthcare提供了更大的可见性和控制力，以实时调整研究。。

'Managing high volumes of data from multiple sources, including wearables that monitor patient health status, is a demanding task,' said Dr. Philip Raeth, managing director at palleos healthcare. 'Unifying data with Veeva Vault EDC and Veeva CDB gives palleos healthcare real-time insight into how a study is progressing, enabling us to better assess and manage outcomes.'.

palleos healthcare总经理Philip Raeth博士说：“管理来自多个来源的大量数据，包括监测患者健康状况的可穿戴设备，是一项艰巨的任务。”与Veeva穹窿EDC和Veeva CDB统一的数据使palleos healthcare实时了解研究的进展情况，使我们能够更好地评估和管理结果。

Based in Germany, palleos healthcare is an international end-to-end full-service contract research organization (CRO) with sponsor capabilities in clinical studies covering phase I-IV drug and medical device trials for various indications, as well as (pre)-clinical consulting services. Using Vault EDC, palleos healthcare can easily design specifications, execute studies, and accommodate mid-study changes with zero downtime.

palleos healthcare总部设在德国，是一家国际端到端全服务合同研究组织（CRO），具有临床研究的赞助商能力，涵盖各种适应症的I-IV期药物和医疗器械试验，以及（预）-临床咨询服务。使用穹窿EDC，palleos healthcare可以轻松设计规格，执行研究，并在零停机时间内适应中期研究变化。

Veeva CDB brings together palleos healthcare's study data from multiple sources into one cohesive data format to make data cleaning, reporting, and export more efficient. .

'palleos healthcare is forward thinking in its management of increasingly complex clinical trials,' said Paul MacDonald, senior director of strategy for Vault CDMS. 'Veeva Vault EDC and Veeva CDB offer palleos healthcare a comprehensive view of their study data, enabling them to further advance clinical trial execution to benefit patients.'.

Vault CDMS is part of Veeva Development Cloud, the operating system for product development that brings together applications for clinical, quality, regulatory, and safety to help organizations drive end-to-end business processes.

穹窿CDM是Veeva开发云的一部分，Veeva开发云是产品开发的操作系统，汇集了临床，质量，监管和安全应用程序，帮助组织推动端到端业务流程。

About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.

关于Veeva SystemsVeeva是生命科学行业云软件的全球领导者。致力于创新，卓越产品和客户成功，Veeva为1000多名客户提供服务，从世界上最大的生物制药公司到新兴生物技术公司。作为一家公益公司，Veeva致力于平衡所有利益相关者的利益，包括客户，员工，股东及其所服务的行业。

For more information, visit veeva.com/eu..

欲了解更多信息，请访问veeva.com/eu。。

Veeva Forward-looking StatementsThis release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements.

Veeva前瞻性声明本版本包含有关Veeva产品和服务的前瞻性声明以及使用我们的产品和服务的预期结果或收益。这些陈述基于我们目前的期望。实际结果可能与本版本中提供的结果有很大不同，我们没有义务更新此类声明。

There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2023, which you can find here (a summary of risks which may impact our business can be found on pages 38 and 39), and in our subsequent SEC filings, which you can access at sec.gov..

有许多风险可能对我们的结果产生负面影响，包括我们在2023年7月31日结束的期间提交的表格10-Q中披露的风险和不确定性，您可以在此处找到（风险摘要可能会影响我们的业务可以在第38页和第39页找到），以及我们随后的SEC申请中，您可以在SEC.gov访问。。

Contact:

联系方式：

Jeremy WhittakerVeeva Systems+49-695-095-5486[email protected]

Jeremy WhittakerVeeva Systems+49-695-095-5486[电子邮件保护]

Heiko Bergmannpalleos healthcare GmbH+49-611-950-190-0 ext. 50[email protected]

Heiko Bergmannpallos healthcare GmbH+49-611-950-90-0分机50[电子邮件保护]

Logo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg

徽标-https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg

SOURCE Veeva Systems

源Veeva系统